[Thirteen reasons why B cell may not be the best therapeutic target in systemic lupus erythematosus]. [electronic resource]
Producer: 20191227Description: 207-210 p. digitalISSN:- 1768-3122
- Antibodies, Monoclonal, Humanized -- adverse effects
- B-Lymphocytes -- physiology
- Drug-Related Side Effects and Adverse Reactions -- epidemiology
- Humans
- Immunotherapy -- adverse effects
- Lupus Erythematosus, Systemic -- epidemiology
- Molecular Targeted Therapy -- adverse effects
- Rituximab -- adverse effects
- Treatment Failure
No physical items for this record
Publication Type: Editorial
There are no comments on this title.
Log in to your account to post a comment.